(October 2, 2024, 1:44 PM EDT) -- NEW YORK — A federal district court in New York correctly dismissed an investor’s putative class complaint asserting securities law violations against a biotechnology company and its principals for failing to adequately plead scienter against any of the defendants, a Second Circuit U.S. Court of Appeals panel found in affirming the ruling....